Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
Newall, Hannah; Myles, Nicholas; Ward, Philip B; Samaras, Katherine; Shiers, David; Curtis, Jackie.
Int Clin Psychopharmacol
; 27(2): 69-75, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21979790
Pharmacological interventions for somatoform disorders in adults.
Glucose dysregulation among veterans living with schizophrenia-related disorders after switching second-generation antipsychotics.
Corrected QT interval changes during electroconvulsive therapy-antidepressants-atypical antipsychotics coadministration: safety issues.
Haloperidol discontinuation for people with schizophrenia.
Zuclopenthixol dihydrochloride for schizophrenia.
A case of recurrent seizures: Drug-drug interaction between low-dose clozapine and extended-release bupropion.
Pharmacological interventions for borderline personality disorder.
Chlorpromazine versus placebo for schizophrenia.
Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.